416 related articles for article (PubMed ID: 22414189)
21. [Emergency treatment of migraine attacks with particular reference to agonists of 5-HT1B/1D receptor].
Prusiński A
Neurol Neurochir Pol; 1999; 32 Suppl 6():39-49. PubMed ID: 11107563
[TBL] [Abstract][Full Text] [Related]
22. [Drug therapy of migraine].
Pfaffenrath V; Reiter M
Wien Med Wochenschr; 1988 Dec; 138(23-24):591-9. PubMed ID: 2906193
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in the acute management of migraine and cluster headaches.
Kumar KL
J Gen Intern Med; 1994 Jun; 9(6):339-48. PubMed ID: 8078000
[TBL] [Abstract][Full Text] [Related]
24. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
[TBL] [Abstract][Full Text] [Related]
25. [Progress of clinical pharmacology in essential headaches].
Fanciullacci M; Franchi G; Galli P
Minerva Med; 1976 Jun; 67(28):1834-9. PubMed ID: 1084498
[TBL] [Abstract][Full Text] [Related]
26. New "triptans" and other drugs for migraine.
Med Lett Drugs Ther; 1998 Oct; 40(1037):97-100. PubMed ID: 9793036
[No Abstract] [Full Text] [Related]
27. Headache.
Raskin NH
West J Med; 1994 Sep; 161(3):299-302. PubMed ID: 7975570
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy.
De Vries P; Villalón CM; Saxena PR
Eur J Pharmacol; 1999 Jun; 375(1-3):61-74. PubMed ID: 10443565
[TBL] [Abstract][Full Text] [Related]
29. [Migraine: selection of therapeutic agents to be applied during its attack].
Yamane K
Nihon Naika Gakkai Zasshi; 2001 Apr; 90(4):601-6. PubMed ID: 11391906
[No Abstract] [Full Text] [Related]
30. Symptomatic treatment of migraine in children: a systematic review of medication trials.
Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
[TBL] [Abstract][Full Text] [Related]
31. Coronary side-effect potential of current and prospective antimigraine drugs.
MaassenVanDenBrink A; Reekers M; Bax WA; Ferrari MD; Saxena PR
Circulation; 1998 Jul; 98(1):25-30. PubMed ID: 9665056
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic and prophylactic treatment of migraine and tension-type headache.
Schulman EA; Silberstein SD
Neurology; 1992 Mar; 42(3 Suppl 2):16-21. PubMed ID: 1557187
[TBL] [Abstract][Full Text] [Related]
33. Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.
Young WB
Headache; 1997; 37 Suppl 1():S42-5. PubMed ID: 9009473
[TBL] [Abstract][Full Text] [Related]
34. Dosing and administration of ergotamine tartrate and dihydroergotamine.
Mathew NT
Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
[TBL] [Abstract][Full Text] [Related]
35. [Drug-induced headache].
Wallasch TM
Fortschr Neurol Psychiatr; 1992 Mar; 60(3):114-8. PubMed ID: 1349547
[TBL] [Abstract][Full Text] [Related]
36. [Drug therapy of migraine and cluster headache].
Heyck H
Dtsch Med Wochenschr; 1975 Jun; 100(23):1293-6. PubMed ID: 237749
[No Abstract] [Full Text] [Related]
37. Migraine treatment: the British perspective.
Wilkinson M
Headache; 1994 Sep; 34(8):S13-6. PubMed ID: 7960723
[TBL] [Abstract][Full Text] [Related]
38. [Current treatment of migraine].
Liaño H
Rev Clin Esp; 1992 Jul; 191(3):161-5. PubMed ID: 1323868
[No Abstract] [Full Text] [Related]
39. When should triptans be taken during a migraine attack?
Schoenen J
CNS Drugs; 2001; 15(8):583-7. PubMed ID: 11524030
[TBL] [Abstract][Full Text] [Related]
40. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ
Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
